Published in Cancer Immun on May 19, 2005
Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation. J Immunother Cancer (2015) 0.88
Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review. Med Oncol (2009) 0.88
On the nature of cancer and why anticancer vaccines don't work. Cancer Cell Int (2005) 0.78
Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma. J Immunother Cancer (2017) 0.75
DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature (2011) 2.23
Elucidating distinct roles for NF1 in melanomagenesis. Cancer Discov (2012) 1.53
Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion. Biol Blood Marrow Transplant (2002) 1.23
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation. Br J Haematol (2009) 1.07
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007. Biol Blood Marrow Transplant (2007) 0.92
Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia. J Mol Diagn (2006) 0.88
Clinical evaluation of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant (2008) 0.87
Immunophenotypic and viral (human papillomavirus) correlates of vulvar seborrheic keratosis. Hum Pathol (2003) 0.85
Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. Biol Blood Marrow Transplant (2012) 0.82